MASSARI, SERENA
 Distribuzione geografica
Continente #
AS - Asia 3.018
NA - Nord America 2.365
EU - Europa 1.889
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 7.289
Nazione #
US - Stati Uniti d'America 2.363
CN - Cina 2.189
IT - Italia 408
IE - Irlanda 397
SE - Svezia 316
SG - Singapore 308
VN - Vietnam 246
HK - Hong Kong 216
UA - Ucraina 205
DE - Germania 119
RU - Federazione Russa 84
FI - Finlandia 82
BE - Belgio 68
GB - Regno Unito 47
FR - Francia 42
RO - Romania 31
AT - Austria 25
PL - Polonia 16
CH - Svizzera 13
CZ - Repubblica Ceca 13
KR - Corea 12
NL - Olanda 11
JP - Giappone 10
CI - Costa d'Avorio 9
IN - India 8
TR - Turchia 7
UZ - Uzbekistan 6
GR - Grecia 5
LB - Libano 5
PK - Pakistan 4
EU - Europa 3
IR - Iran 3
BG - Bulgaria 2
EG - Egitto 2
ES - Italia 2
HU - Ungheria 2
BR - Brasile 1
CA - Canada 1
CL - Cile 1
DK - Danimarca 1
ID - Indonesia 1
IQ - Iraq 1
KZ - Kazakistan 1
MX - Messico 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 7.289
Città #
Guangzhou 2.074
Chandler 572
Dublin 397
Singapore 266
Dong Ket 243
Hong Kong 207
San Mateo 201
Perugia 199
Boardman 152
Santa Clara 115
Jacksonville 108
Medford 89
Princeton 88
Altamura 82
Ann Arbor 71
Brussels 68
Lawrence 60
Wilmington 60
Beijing 56
Fremont 44
Andover 41
West Jordan 38
Redmond 31
Bucharest 25
Saint Petersburg 25
Dearborn 23
Helsinki 22
Vienna 21
Norwalk 20
Redwood City 17
Spoleto 16
Ashburn 15
Dallas 13
Munich 13
Des Moines 12
Hanover 11
Los Angeles 11
New York 10
Seoul 10
Woodbridge 10
Abidjan 9
Moscow 8
Den Haag 7
Izmir 7
Radomsko 7
Falls Church 6
Frankfurt Am Main 6
Olomouc 6
Tokyo 6
Anguillara Sabazia 5
Philadelphia 5
San Paolo di Civitate 5
West Lafayette 5
Campegine 4
Fairfield 4
Milan 4
Romola 4
San Jose 4
Shanghai 4
Xian 4
Brno 3
Chicago 3
Hanoi 3
Kunming 3
Napoli 3
Nichelino 3
Rome 3
San Giustino 3
Siena 3
Timisoara 3
Auburn Hills 2
Barceloneta 2
Berlin 2
Cairo 2
Cambridge 2
Genova 2
Gradara 2
Gujranwala 2
Houston 2
Indore 2
Jinan 2
Kagoya 2
Lausanne 2
London 2
Macerata 2
Mcallen 2
Nanjing 2
Nantong 2
Padova 2
Pasadena 2
Reading 2
San Gemini 2
Simi Valley 2
Tappahannock 2
Tricesimo 2
Umbertide 2
Urbino 2
Western Springs 2
Zhengzhou 2
Absecon 1
Totale 5.735
Nome #
Structural investigation of Small Molecules Targeting Influenza A Virus Polymerase 2.099
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 230
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 196
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 117
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 106
SINTESI DI NUOVI INIBITORI DELLA POMPA DI EFFLUSSO NorA DELLO S. aureus: DALLE 3-FENIL-1,4-BENZOTIAZINE ALLE 2-FENILCHINOLINE 94
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 94
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 89
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 78
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 78
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 77
Disegno e Sintesi di Nuovi Inibitori Allosterici della NS5B Polimerasi dell'HCV 74
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 74
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 74
CYCLOHEPTATHIOPHENE-3-CARBOXAMIDE DERIVATIVES AS INFLUENZA A VIRUS POLYMERASE INHIBITORS 74
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 73
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 72
Acting on Tat-Mediated Transcription to Achieve a Long Term Control of HIV-1 Latency 72
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 72
6-Desfluoroquinolones as promising HIV transcription inhibitors 71
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 71
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 70
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 69
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 69
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 69
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 68
2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors 68
A new quinolone derivative with ultra-potent anti-HIV activity. 65
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 65
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 65
A New Derivative with Ultra-Potent Anti-HIV Activity 64
4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10 64
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 64
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 63
From 6-Aminoquinolone Antibacterials to 6-Amino-7-thiopyranopyridinylquinolone Ethyl Esters as Inhibitors of Staphylococcus aureus Multidrug Efflux Pumps. 62
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 61
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 61
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein 60
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 60
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 60
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 59
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 58
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 58
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 58
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 58
Nuovi 6-DFQ come inibitori della Transattivazione dell’HIV-1 57
Disegno e sintesi di agenti anti-HIV a duplice attività 57
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 57
Biotinylated Tryptophan Catabolites for Target Fishing. 55
New compounds targeting the rna polymerase of influenza a and b viruses. 55
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 55
[1,2,4]Triazolo[3,4-b]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes 53
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 53
The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication 52
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo [4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia 52
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity 50
6-Aminoquinolones targeting HCV NS5B polymerase. 49
Nuovi 6-DFQ come inibitori della transattivazione dell’HIV-1. Abstr O15 48
Designed Multiple Ligands (DLMs) as innovative anti-HIV agents 48
Re-evolution of the 2-phenylquinolines: Ligand-Based Design, Synthesis, and Biological Evaluation of a Potent New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors to Combat Antimicrobial Resistance 48
Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-protein Interaction as a Target for Next-generation Anti-influenza Therapeutics. 48
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 47
Cycloheptathiophene-3-carboxamide derivatives as influenza A virus polymerase inhibitors 47
Studies of Anti-HIV Transcription Inhibitor Quinolones: Identification of Potent N1-Vinyl Derivatives 46
Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands 44
Design, Synthesis, and Evaluation of WC5 Analogues as Inhibitors of Human Cytomegalovirus Immediate-Early 2 Protein, a Promising Target for Anti-HCMV Treatment 43
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 42
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 41
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 41
Phospholipidosis effect of drugs by adsorption into lipid monolayers 40
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 40
Targeting the HIV Tat-mediated transcriptional machinery: P-TEFb complex inhibitors 38
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 38
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 38
Structural investigation of the naphthyridone scaffold: identification of a 1,6-naphthyridone derivative with potent and selective anti-HIV activity. 36
Reducing Mutant Huntingtin Protein Expression in Living Cells by a Newly Identified RNA CAG Binder. 36
Studies on anti-HIV Quinolones 35
Structural Investigation of Cycloheptathiophene-3-carboxamide Derivatives Targeting Influenza Virus Polymerase Assembly 35
Small molecole targeting HPV E6 and E7 oncoproteins expression. 35
NM13, UN NUOVO POTENTE E SELETTIVO AGENTE ANTI-HIV 34
Ethyl 1,8-Naphthyridone-3-carboxylates Downregulate Human Papillomavirus-16 (HPV-16) E6 and E7 Oncogenes Expression 33
Blocking HIV-1 Replication by Targeting the TAT-Hijacked Transcriptional Machinery 32
SMALL MOLECULES TARGETING HPV E6 AND E7 ONCOPROTEINS EXPRESSION 32
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 31
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 30
Triazolopyrimidine nuclei: privileged scaffolds for developing antiviral agents with a proper pharmacokinetic profile. 30
TARGETING CDKs TO INHIBIT THE HIV-1 TAT-MEDIATED TRANSCRIPTION 29
Compounds for use in the treatment of cancer and inflammatory conditions 27
Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15 25
From Small to Powerful: The Fragments Universe and its "Chem-Appeal" 25
Protein-protein interactions by influenza polymerase subunits as drug targets 24
In Vitro effects of alternative smoking devices on oral cells: Electronic cigarette and heated tobacco product versus tobacco smoke 23
Recent advances in the identification of Tat-mediated transactivation inhibitors: progressing toward a functional cure of HIV 21
Small Molecules Targeting DNA Polymerase Theta (POLθ) as Promising Synthetic Lethal Agents for Precision Cancer Therapy 20
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity 20
Modulation of HIV-1-Induced Activation of Plasmacytoid Dendritic Cells by 6-Desfluoroquinolones 19
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 17
Discovery of 2‐phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate 16
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 14
Q-raKtion: A Semiautomated KNIME Workflow for Bioactivity Data Points Curation 13
Totale 7.577
Categoria #
all - tutte 25.293
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.293


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020284 0 0 0 0 40 27 58 12 54 69 6 18
2020/2021935 13 57 33 57 204 81 87 5 71 31 37 259
2021/2022940 31 144 18 66 73 7 24 242 69 35 111 120
2022/20231.588 96 281 19 161 155 151 3 102 514 15 57 34
2023/20242.830 39 116 37 24 14 22 2.246 16 57 57 78 124
2024/2025531 19 150 65 139 158 0 0 0 0 0 0 0
Totale 7.580